i-SENS, Inc. (KOSDAQ:099190)

Market Cap	506.69B +17.3%
Revenue (ttm)	315.44B +8.3%
Net Income	-5.15B
EPS	-187.00
Shares Out	28.76M
PE Ratio	n/a
Forward PE	110.82
Dividend	100.00 (0.56%)
Ex-Dividend Date	Dec 29, 2025

Volume	110,810
Average Volume	134,818
Open	18,050
Previous Close	18,000
Day's Range	17,250 - 18,060
52-Week Range	14,600 - 27,600
Beta	1.01
RSI	34.04
Earnings Date	May 22, 2026

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headq...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2000
• Employees: 887
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099190

Financial Performance

In 2025, i-SENS's revenue was 315.44 billion, an increase of 8.35% compared to the previous year's 291.14 billion. Losses were -5.15 billion, 187.0% more than in 2024.